logo-white
logo-color

Abacus Medicine Pharma Services is a fast-growing company with a strong, entrepreneurial spirit. When change is constant, experience is invaluable.

Our management team understand the global pharmaceutical landscape, and are experts in the development and delivery of healthcare and pharma services. This industry leading team have extensive knowledge and experience, and are dedicated to building a new generation company to support the next generation of pharmaceutical products.
Simon Estcourt

Simon Estcourt

Managing Director

READ MORE
Maxine Hamilton

Maxine Hamilton

Chief Operating Officer

READ MORE

The dedicated personnel of Abacus Medicine Pharma Services are always ready to assist all of our pharmaceutical clients and business partners across the entire pharmaceutical lifecycle.

Clinical Trial Solutions

Ian Hoban

Ian Hoban

Business Development Director – CTS
Mail: ian.hoban@abacusmedicine.com

Managed Access Programs

Martin Harper

Martin Harper

VP – Pharma Services EMEA
Mail: martin harper@abacusmedicine.com

Unlicensed Medicines

Commercial Partnerships

Richard Edwards

Richard Edwards

Head of Unlicensed Medicine – EMEA Mail: richard.edwards@abacusmedicine.com
William Van

William Van

General Manager – APAC
Mail: william.van@abacusmedicine.com

Commercial Partnerships

Mark Ostle

Mark Ostle

VP – Strategic Partnerships
Mail: mark.ostle@abacusmedicine.com

Gary Kahn

Gary Kahn

VP – Business Development
Mail: gary.kahn@abacusmedicine.com

Unlicensed Medicines

Richard Edwards

Richard Edwards

Head of Unlicensed Medicine – EMEA Mail: richard.edwards@abacusmedicine.com
William Van

William Van

General Manager – APAC
Mail: william.van@abacusmedicine.com

Commercial Partnerships

Mark Ostle

Mark Ostle

VP – Strategic Partnerships
Mail: mark.ostle@abacusmedicine.com

Gary Kahn

Gary Kahn

VP – Business Development
Mail: gary.kahn@abacusmedicine.com

Simon Estcourt

Simon Estcourt

Managing Director

A senior executive in the Healthcare and Pharma Services industry, Simon brings over 25 years of experience to Abacus Medicine Pharma Services.

His career moved quickly after joining Servier where he became UK Sales Director, before broadening his horizons with a move to Quintiles. He worked with many of the leading pharma manufacturers in global operational and business development roles.

In 2007, he joined Idis to establish the Pharmaceutical Services Division and led on strategy and corporate development for the organisation. Simon and his teams developed a new category of pharmaceutical service that has now become known as Managed Access Programs.

Working in partnership with over 70 pharma and biotech companies, these programs benefited thousands of patients globally who were able to access previously unavailable medicines.

The success of Idis led to an acquisition by Clinigen, where Simon continued as Chief Operating Officer and latterly Chief Strategy Officer.

Maxine Hamilton

Maxine Hamilton

Chief Operating Officer

Following a successful career in client management and program delivery, Maxine joined Abacus Medicine Pharma Services in February 2019.

Maxine entered the pharma industry in 2005 leading the UK arm of Idis’ General Sales Division. In 2008, she joined the Managed Access Division as Director of Program Management working as an industry expert developing, managing and implementing more than 200 global access programs and solutions.

As a member of the global leadership team and SVP Managed Access Programs, based in Princeton NJ, she was instrumental in defining and implementing corporate strategy, direction and growth of the US operation.

In 2015, following the acquisition by Clinigen, Maxine was appointed Managing Director of Managed Access and led the division across multiple sites including the US, Italy, France and the UK to achieve revenue and GP targets.